Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-03-07 Sale |
2024-03-07 5:46 pm |
Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO |
48,202 | $0 | $0 | 0 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-07 5:41 pm |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
22,936 | $0 | $0 | 0 (Direct) |
View |
| 2023-10-27 Sale |
2023-10-31 5:00 pm |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
12,778 | $9.82 | $125,480 | 130,079 (Direct) |
View |
| 2023-10-27 Sale |
2023-10-31 5:00 pm |
Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO |
50,012 | $9.82 | $491,118 | 342,845 (Direct) |
View |
| 2023-10-23 Purchase |
2023-10-25 4:15 pm |
Ambrx Biopharma Inc. | AMAM | Cormorant Asset Management LP Chen Bihua Cormorant Global Healthcare Master Fund LP Cormorant Private Healthcare Fund III LP 10% Owner |
1,307,311 | $6.9911 | $9,139,542 | 11,231,000 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-12-11 Option Award |
2023-12-11 5:19 pm |
N/A N/A |
Ambrx Biopharma Inc. | AMAM | Aromando Andrew Chief Operating Officer |
100,000 | $0 | 109,263 (Direct) |
View |
| 2023-12-11 Option Award |
2023-12-11 5:17 pm |
N/A N/A |
Ambrx Biopharma Inc. | AMAM | Nelson Sonja Chief Financial Officer |
50,000 | $0 | 545,776 (Direct) |
View |
| 2023-12-11 Option Award |
2023-12-11 5:15 pm |
N/A N/A |
Ambrx Biopharma Inc. | AMAM | O'Connor Daniel J. President and CEO |
750,000 | $0 | 1,363,332 (Direct) |
View |